US 11530244
Cyclic polypeptides for PCSK9 inhibition
granted A61KA61K38/00A61P
Quick answer
US patent 11530244 (Cyclic polypeptides for PCSK9 inhibition) held by RA PHARMACEUTICALS, INC. expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RA PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61P, A61P3/06, A61P9/10